Fluxergy, founded in 2013, seeks to provide a portable, easy-to-use sample-to-answer platform that enables clinicians to cost-effectively conduct a wide range of sophisticated multiplex and
A pioneer in the field of POCT (Point Of Care Testing) A pioneer in the field of POCT that owns the technology to develop and manufacture the world's best microfluid chips. NanoEntek possesses a key
DiagnostikNet-BB is a network of diagnostics providers, device manufacturers, research institutes, clinics and medical laboratories as well as expert partners across Germany, with its core in the
PASTEUR PIPETTE Code Material &
Atlas Medical is introducing COVID-19 IgG/IgM Antibody Rapid Test as a screening tool for the human body response to infection with the virus. Detecting antibodies to SARS-CoV-2 virus could tell if a
(AFP) Alpha-Fetoprotein Test is designed for the rapid qualitative determination of AFP in whole blood, serum or plasma specimens to aid in the diagnosis of Hepatocelluar Carcinoma or fetal open
Summary Urinalysis Reagent Strips are made for urinalysis of both qualita tive and semi-quantitative, which are in vitro reagent for diagnos tics. It tests Leukocytes, Nitrite, Urobili nogen,
• Test COVID-19 both IgG and IgM Ab • Rapid result in in 10min. • Whole blood (Finger prick available), serum and plasma sample • Easy to use no analyzer required • Store at room temperature or
Biomarkers are measurable parameters that can indicate pathological processes in the body. They can be measured from a tissue biopsy or a liquid biopsy like blood, urine or saliva. All specimens come
CHEXEL™ Cardiac TnI Test System - Launching is expected in Q2 2021 - CE marking is expected in Q4 2021 KEY FEATURES & BENEFITS - Rapid immunoassay - Small sample volume analysis - High
CHEXEL™ COVID-19 Antigen Test Kit - Launching is expected in December 2020 - CE marking is expected in Q1 2021 KEY FEATURES & BENEFITS - Accurate & compact/Easy-to-use - Rapid
CHEXEL™ COVID-19 IgM/IgG Test Kit (CAT# GQLAGH) KEY FEATURES & BENEFITS - CE-IVD marked - Accurate & compact/Easy-to-use - Rapid immunoassay - Small sample volume analysis - High
For a more sustainable future. And higher quality of your results. Abcalis is specialized in a new class of recombinant antibodies for diagnostics. Our antibodies are carefully selected via
Abcalis® anti-SARS-CoV-2 antibodies are high quality recombinant monoclonal primary antibodies Abcalis product portfolio now also features anti-SARS-CoV-2 recombinant (sequence defined)
Improving life with rapid testing. Abingdon Health provides lateral flow assay development alongside Europes largest rapid test manufacturing capcity to a multi-industry, global
ABSOLOGY is a company that develops and mass-produces in vitro diagnostic medical devices. ABSOL, which is an in-vitro-diagnostic immunoassay system, is one of the main items of the company. The
Absoludy COVID-19 Ag Rapid is based on immunochromatography for the qualitative determination of SARS-CoV-2 virus specific antigens in human nasopharynx swab specimen. Absoludy COVID-19 Ag Rapid Card
Absoludy COVID-19 IgM/IgG Rapid is based on the principle of an immune-chromatography in vitro test for the qualitative determination of SARS-CoV-2 virus (COVID-19) specific IgM or IgG in serum,
KEY POINTS Detection for: qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum, or plasma as an aid in the diagnosis of primary and secondary COVID-19 infections.
KEY POINTS Detection for: IgG and IgM antibodies and non-structural protein antigen to Dengue virus in human whole blood, serum, or plasma Specimen volume: Serum or Plasma Specimens: for IgG/IgM Test
Page 1 of 34
To use the full function of this web site, JavaScript needs to be enabled in your browser.
This is how you enable JavaScript in your browser settings: Read instruction